Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis

Bibliographic Details
Main Authors:	Chenghua Weng, Zhichun Liu, Lishao Guo
Format:	Article
Language:	English
Published:	Wolters Kluwer 2022-09-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000002049

Similar Items

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
by: Anaïs Nombel, et al.
Published: (2021-10-01)

Editorial: Anti-MDA5-Positive Dermatomyositis
by: Takahisa Gono, et al.
Published: (2022-05-01)

Blood purification in two patients with clinically amyopathic dermatomyositis associated with interstitial lung disease with anti-melanoma differentiation-associated gene-5 antibody (MDA-5)
by: Han-yu Shi, et al.
Published: (2019-01-01)

Clinical Images: Cutaneous ulcerations in anti‐MDA‐5 dermatomyositis
by: Eaman Alhassan, et al.
Published: (2024-03-01)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
by: Anca Bobirca, et al.
Published: (2022-07-01)

Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers
by: Büşra Demirbağ Gül, et al.
Published: (2022-12-01)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
by: Shuang Zhou, et al.
Published: (2022-08-01)

Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis complicated with macrophage activation syndrome
by: Yukang Ding, et al.
Published: (2022-05-01)

Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis
by: Ho So, et al.
Published: (2022-02-01)

Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis
by: Yan Wang, et al.
Published: (2023-08-01)

A Review of MDA-5 Dermatomyositis and Associated Interstitial Lung Disease
by: Sambhawana Bhandari, et al.
Published: (2024-02-01)

Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis
by: Tao Liu, et al.
Published: (2022-08-01)

Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering
by: Ruru Guo, et al.
Published: (2024-03-01)

Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud
by: Jinming Yang, et al.
Published: (2022-10-01)

Palmar and lateral digital papules as a distinct feature of fatal anti-melanoma differentiation-associated gene 5 dermatomyositis
by: Tzong-Yun Ger, et al.
Published: (2020-01-01)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
by: Anne-Claire Billet, et al.
Published: (2022-12-01)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
by: Houari Aissaoui, et al.
Published: (2021-04-01)

Association of Cytomegalovirus Infection With Anti-MDA5 Antibody-Positive Dermatomyositis: A Prospective Cohort Study
by: Linlin Huang, et al.
Published: (2021-10-01)

Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report
by: Yida Xing, et al.
Published: (2023-12-01)

Pattern Recognition by Melanoma Differentiation-Associated Gene 5 (Mda5) in Teleost Fish: A Review
by: Jassy Mary S. Lazarte, et al.
Published: (2019-04-01)

Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
by: Lei Wang, et al.
Published: (2024-02-01)

Machine learning for screening and predicting the risk of anti-MDA5 antibody in juvenile dermatomyositis children
by: Yuan Xue, et al.
Published: (2023-01-01)

Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis
by: Yanyan Jiang, et al.
Published: (2021-03-01)

Demyelinating polyneuropathy, dermatomyositis, and interstitial pneumonitis associated with autoantibody against melanoma differentiation-associated gene 5
by: Yu-Hsiang Chiu, et al.
Published: (2017-01-01)

Coexistence of anti‐MDA5 and anti‐PL‐7 in a patient with dermatomyositis: A case report
by: Hongyan Fu, et al.
Published: (2023-01-01)

Aberrantly Expressed Galectin-9 Is Involved in the Immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease
by: Lin Liang, et al.
Published: (2021-03-01)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
by: Kei Ikeda, et al.
Published: (2023-01-01)

Acquired reactive perforating collagenosis – A rare cutaneous manifestation of anti-MDA5 dermatomyositis
by: Teck Sheng Gan, et al.
Published: (2022-01-01)

Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient
by: Nouf Alqahtani, et al.
Published: (2021-09-01)

Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report
by: Antonino Marcello Pilia, et al.
Published: (2024-03-01)

Managing a Case of Refractory Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Dermatomyositis with Recent COVID-19 Infection
by: Cheryl Chun Man Ng, et al.
Published: (2023-07-01)

Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo.
by: Leonid Gitlin, et al.
Published: (2010-01-01)

Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis
by: Meiqi Li, et al.
Published: (2023-08-01)

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
by: Man Luo, et al.
Published: (2022-05-01)

Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis
by: Anusha Vuppala, et al.
Published: (2023-12-01)

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis
by: Christopher A. Mecoli, et al.
Published: (2022-05-01)

Therapeutic options in refractory anti-MDA5 dermatomyositis triggered by SARS-CoV-2 infection
by: Elena Juganaru, et al.
Published: (2022-09-01)

Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients
by: Jinjing Qian, et al.
Published: (2023-03-01)

Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom
by: Yuki Hattori, et al.
Published: (2018-05-01)

Spontaneous Intramuscular Hemorrhage in Anti-MDA5 Positive Dermatomyositis: A Case Series and Literature Review
by: Zhangling Xu, et al.
Published: (2022-01-01)